… be used in patients with any of the following:
• hypersensitivity to the active substance, or to any of the excipients listed in section 6.1
• cardiogenic shock
• uncontrolled heart failure
• sick sinus syndrome
• second-or third-degree heart block
• untreated phaeochromocytoma
• metabolic acidosis
• bradycardia (<45 bpm)
• hypotension
• severe peripheral arterial circulatory disturbances.
Identical in all 6 labels. Surrounding text shown from Aurobindo Pharma - Milpharm Ltd..
Co-tenidone should not be used in the following:
• hypersensitivity to the active substances (or to sulphonamide derived medicinal products) or to any of the excipients listed in section 6.1
• bradycardia
• cardiogenic shock
• hypotension
• metabolic acidosis
• severe peripheral arterial circulatory disturbances
• second- or third-degree heart block
• sick sinus syndrome
• untreated pha …
Identical in both labels. Surrounding text shown from Wockhardt UK Ltd.
… lol tablets, as with other beta-blockers, should not be used in patients with any of the following:
• hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
• second-degree or third-degree heart block.
• bradycardia (<45 bpm).
• Uncontrolled heart failure.
• cardiogenic shock.
• sick sinus syndrome.
• untreated phaeochromocytoma.
• severe peripheral arterial circulatory disturbances.
…
Atenolol, as with other beta blockers, should not be used in patients with any of the following:
- Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
- Second or third-degree heart block.
- Cardiogenic shock.
- Uncontrolled heart failure.
- Sick sinus syndrome (including sino-atrial block).
- Untreated phaeochromocytoma.
- Metabolic acidosis
- Bradycardia (less than 45-50 beats …